期刊文献+

甲地孕酮联合格拉司琼预防化疗所致消化道反应的疗效观察 被引量:2

Clinical Observation of Megestrol Acetate plus Granisetron in the Preventive Treatment of Gastrointestinal Induced by Chemotherapy
下载PDF
导出
摘要 目的观察甲地孕酮联合格拉司琼预防化疗所致消化道反应的疗效及毒副反应。方法将76例接受含顺铂、阿霉素及环磷酰胺联合化疗的恶性肿瘤患者随机分为治疗组和对照组。治疗组止吐方案:甲地孕酮+格拉司琼+甲氧氯普胺;对照组止吐方案:格拉司琼+甲氧氯普胺,2周期后评价疗效。结果Ⅱ度以上急性恶心、呕吐及迟发性恶心呕吐发生率,治疗组分别为5.3%、9.2%及6.6%;对照组分别为23.7%、28.9%及21.1%,2组比较差异均有统计学意义(P均<0.05)。治疗后治疗组生活质量改善明显优于对照组(P<0.05)。2组毒副反应相近,均较轻微,可耐受。结论甲地孕酮联合格拉司琼预防化疗所致恶心呕吐较单用格拉司琼具有更好的预防效果,并可明显改善患者的生活质量。 Objective To observe the effect and toxicities of megestrol acetate plus granisetron in the preventive treatment of gastrointestinal reaction induced by chemotherapy. Methods All the 76 patients treated by cisplatin, adriamycin and cyclophosphamide were devided into the treatment group and the control group randomly. The patients of the treatment group were treated with megestrol acetate + granisetron + metoclopramide, those of the control group were treated with granisetron + metoclopramide, the effect and toxicities were evaluated after 2 cycles of treatment. Results The incidence of grade Ⅱ -Ⅳ acute nausea,acute vomiting and delayed nausea and vomiting in the treatment group were 5.3% ,9.2% and 6.6% ; and those of the control group were 23.7% ,28.9% and 21.1% , the differences between the two groups were statistically significant ( P 〈 0.05 ). The quality of life after chemotherapy in the treatment group was superior to the control group. The toxicities in two groups were similar and relatively mild. Conclusion Megestrol acetate plus granisetron in preventing nausea and vomiting induced by chemotherapy is superior to granisetron alone, and can improve the quality of life of the patients obviously.
出处 《肿瘤基础与临床》 2012年第3期249-251,共3页 journal of basic and clinical oncology
关键词 甲地孕酮 格拉司琼 化疗 消化道反应 megestrol acetate granisetron chemotherapy gastrointestinal reaction
  • 相关文献

参考文献8

二级参考文献58

  • 1张晓静,张频.肿瘤化疗所致恶心呕吐的发生机制和药物治疗的研究进展[J].癌症进展,2006,4(4):348-354. 被引量:128
  • 2Wiser W, Berger A. Practical management of chemotherapy-duced nausea and vomiting[J]. Oncology (Williston Park), 2005, 19(5):637-645.
  • 3Fiorica J V, Brunetto V L, Hanjani P, et al. Phase Ⅱ trial of al ternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gymecologic Oncology Group study [J]. Gynecol Oncol, 2004,92 (1) : 10-14.
  • 4Ruiz Oarcia V,Juan O,Perez Hoyos S,et al. Megestrol acetate:a systematic review usefulness about the weight gain in neoplastic Clin ( Barc), 2002,119 ( 5 ) : 166.
  • 5Cubeddu L X. Serotonin mechanisms in chemotherapy induced emesis in cancer patients[J]. Oncology, 1996, 53(Suppl 1) : 18-25.
  • 6Roila F, Donati D, Tamberi S, et al. Delayed emesis:Incidence, pattern, prognostic factors and optimal treatment[J]. Support Care Cancer, 2002,10(2): 88-95.
  • 7[1]Wiser W,Berger A.Practical management of chemotherapy-induced nausea and vomiting.Oncology Williston Park),2005,19:637
  • 8[2]Aapro M,et al.Palonosetron is effective in preventing acute and delayed chemotherapy-induced nausea and vomiting in patients recieving highly emetogenic chemotherapy (HEC)[Abstract].Support Care Cancer,2003,11:A17
  • 9[3]Jordan K,Kasper C,Schmoll HJ.Chemotherapy-induced nausea and vomiting:Current and new standards in the antiemetic prophylaxis and treatment.Eur J Cancer,2005,41:199
  • 10[4]Roila F,Donati D,Tamberi S,et al.Delayed emesis:Incidence,pattern,prognostic factors and optimal treatment.Support Care Cancer,2002,10:88

共引文献139

同被引文献11

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部